Log In

    Geovax Labs (GOVX)

    GeoVax Receives BARDA Award For COVID Vaccine Trial

    ‌
    Robert LeBoyerMedia Inquiries
    Senior Life Sciences Analyst
    June 18, 2024
    Report ID: 26813
    Get Report
    Refer to the full report for the price target, fundamental analysis, and rating.
    Get Report

    Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

    Already Registered? Click the ‘Get Report’ button to login and view the research report.

    Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

    ‌
    Geovax Labs
    Geovax Labs
    Healthcare
    Biotechnology
    Ticker
    GOVX
    Current Price
    $3.28 2.98%
    Market Cap
    $7.6M
    Price Target
    Refer to Report
    Volume
    5.4M
    52wk Range
    $1.0901 - $10.2405
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Related Research Reports
    6/28/2024
    ‌
    CRO Partnership For Clinical Trial Allows Sponsored Phase 2b Trial To Move Forward
    CRO Partnership For Clinical Trial Allows Sponsored Phase 2b Trial To Move Forward (GOVX)
    4 min read
    6/18/2024
    ‌
    GeoVax Receives BARDA Award For COVID Vaccine Trial
    GeoVax Receives BARDA Award For COVID Vaccine Trial (GOVX)
    0 min read
    5/15/2024
    ‌
    1Q24 Reported With Clinical Milestones Later In FY2024
    1Q24 Reported With Clinical Milestones Later In FY2024 (GOVX)
    0 min read
    3/7/2024
    ‌
    Vaccine Production Technology Reaches Milestone With Manufacturing Facility Validation
    Vaccine Production Technology Reaches Milestone With Manufacturing Facility Validation (GOVX)
    0 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In